Panakes Partners Announces the hiring of Dr. Marco Sardina as Scientific Partner and Dr. Andrea Ballerini as Associate
Milan, Italy - July 28, 2021
Panakes Partners SGR, a leading Venture Capital investor creating and building the next generation of innovative European Life Science companies, announced today that Dr. Marco Sardina has joined the team as Scientific Partner and Dr. Andrea Ballerini as Associate.
Marco is a physician by education and training, with a PhD in Clinical Pharmacology. He has over thirty years of diverse international experience, ranging from leading clinical research projects from Phase I to IV, R&D, Medical Affairs team, supporting Business Development and in/out licensing processes. Marco is a recognized expert in drug discovery & development with proven record of advancing projects from discovery to proof-of-concept in clinical stage and marketing approval in different fields. He was also Partner in a corporate venture company and most recently CSO in BiovelocITA, Italy’s leading Biotech focused accelerator. Marco is Scientific Advisory Board member of innovative startups, author of more than 140 scientific publications and four patents. He is Fellow of the International College of Angiology, member of the Faculty of Pharmaceutical Medicine and of the New York Academy of Sciences.
Andrea is a medical doctor specialized in clinical pharmacology, with expertise in evaluating, selecting, and developing early-stage potential breakthrough therapies that could solve unmet medical needs. In addition, Andrea has spent time in the USA working on nanotech and medical devices, broadening his view on possible different therapeutic approaches beside using small molecules, biologics, and cell therapies. He worked for the last four years at BiovelocITA alongside Marco, managing the development of preclinical assets developed by Italian research institutions.
Fabrizio Landi, General Partner and Chairman of Panakes Partners, said: "We are very pleased to have Marco and Andrea join us. Alongside the future Biotech Partner, who will join us in the coming months, Marco and Andrea will be an integral part of the Panakes team as we ramp up our biotech activities, leveraging their complimentary expertise in the fields of drug development, company creation and investment.”
"I am delighted to join Panakes Partners at this exciting time; with the new fund, Panakes will expand its focus to innovative startups in all segments of Life Sciences including Biotech and Advanced Therapies. The collective expertise of the Panakes team will provide unique strategic and operational support that will drive successful investments representing a new paradigm in the Life Sciences arena” said Marco Sardina.
"I am happy to join Panakes team and look forward to supporting the development of innovative approaches that could transform the care of patients,” said Andrea Ballerini. “I am excited to join a team with such diverse skills, with the shared goal of identifying and supporting the development of game-changing technologies and medicines. The Covid-19 pandemic has taught us is that there will always be a need for innovation in healthcare, and the Panakes team will be well positioned to make a meaningful contribution to this effort”
About Panakes Partners
Panakes is a Venture Capital firm with the ultimate goal of providing a better life to people all around the world, by providing both financial and business support to build the next generation of game-changing technologies companies in the field of Life Sciences. Panakes invest in ambitious start-ups and SMEs with innovative products globally, with a focus on Europe, US and Israel. Panakes HQ is in Milan, Italy.